Caldesene Medicated Protecting Powder
NDC Package 63736-306-01
Package Information
Caldesene Medicated Protecting (cornstarch and zinc oxide) powders is for diaper rashchange wet or soiled diapers promptlycleanse the diaper area and allow to dryapply powder liberally, as often as necessary, with each diaper change, especially at bedtime or anytime exposure to wet diapers may be prolongedapply powder close to the body away from child's facecarefully shake the powder into the diaper or into the hand and apply to diaper areaFor minor skin irritationssmooth on powder to protect irritated and chafed skin. This formulation utilizes a powder delivery system. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-306 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 1039054 - corn starch 81 % / zinc oxide 15 % Topical Powder
- RxCUI: 1039054 - starch 0.81 MG/MG / zinc oxide 0.15 MG/MG Topical Powder
- RxCUI: 1039054 - Starch 0.81 MG/MG / ZNO 0.15 MG/MG Topical Powder
- RxCUI: 1039057 - Caldesene Baby 81 % / 15 % Topical Powder
- RxCUI: 1039057 - starch 0.81 MG/MG / zinc oxide 0.15 MG/MG Topical Powder [Caldesene]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals Llc
- 63736-306 - Caldesene Medicated Protecting
- 63736-306-01 - 142 g in 1 BOTTLE
- 63736-306 - Caldesene Medicated Protecting
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-306-01 identifies a specific commercial package of 142 g in 1 bottle of Caldesene Medicated Protecting, a human over the counter drug labeled by Insight Pharmaceuticals Llc. This powder is formulated for topical use and contains starch, corn; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Insight Pharmaceuticals Llc on July 15, 2017. The current certification is valid through December 31, 2027.
How is this Insight Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736030601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.